Joerg Hoffmann

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Topics

Ankylosing Spondylitis

Artificial Intelligence

Chronic Lymphocytic Leukemia

Top Venues

Current oncology (Toronto, Ont.)

Cytometry. Part B, Clinical cytometry

Cytometry. Part A : the journal of the International Society for Analytical Cytology

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Joerg Hoffmann, Semil Eminovic, Christian Wilhelm, Stefan W Krause, Andreas Neubauer, Michael C Thrun, Alfred Ultsch, Cornelia Brendel
Prediction of Clinical Outcomes with Explainable Artificial Intelligence in Patients with Chronic Lymphocytic Leukemia. Current oncology (Toronto, Ont.) 30 (2) (2023)
Joerg Hoffmann, Semil Eminovic, Christian Wilhelm, Stefan W Krause, Andreas Neubauer, Michael C Thrun, Alfred Ultsch, Cornelia Brendel
Prediction of Clinical Outcomes with Explainable Artificial Intelligence in Patients with Chronic Lymphocytic Leukemia. Current oncology (Toronto, Ont.) 30 (2) (2023)
Joerg Hoffmann, Semil Eminovic, Christian Wilhelm, Stefan W Krause, Andreas Neubauer, Michael C Thrun, Alfred Ultsch, Cornelia Brendel
Prediction of Clinical Outcomes with Explainable Artificial Intelligence in Patients with Chronic Lymphocytic Leukemia. Current oncology (Toronto, Ont.) 30 (2) (2023)
Joerg Hoffmann, Semil Eminovic, Christian Wilhelm, Stefan W Krause, Andreas Neubauer, Michael C Thrun, Alfred Ultsch, Cornelia Brendel
Prediction of Clinical Outcomes with Explainable Artificial Intelligence in Patients with Chronic Lymphocytic Leukemia. Current oncology (Toronto, Ont.) 30 (2) (2023)
Joerg Hoffmann, Semil Eminovic, Christian Wilhelm, Stefan W Krause, Andreas Neubauer, Michael C Thrun, Alfred Ultsch, Cornelia Brendel
Prediction of Clinical Outcomes with Explainable Artificial Intelligence in Patients with Chronic Lymphocytic Leukemia. Current oncology (Toronto, Ont.) 30 (2) (2023)
Joerg Hoffmann, Georg Schliesser, Andreas Neubauer
Abatacept as salvage therapy for life-threatening refractory autoimmune hemolytic anemia: a case report. Hematology (Amsterdam, Netherlands) 28 (1) (2023)
Joerg Hoffmann, Semil Eminovic, Christian Wilhelm, Stefan W Krause, Andreas Neubauer, Michael C Thrun, Alfred Ultsch, Cornelia Brendel
Prediction of Clinical Outcomes with Explainable Artificial Intelligence in Patients with Chronic Lymphocytic Leukemia. Current oncology (Toronto, Ont.) 30 (2) (2023)
Joerg Hoffmann, Samira Roesner, Andreas Neubauer
Rituximab induces a flare-up of activated neutrophil extracellular traps under in vitro conditions. Immunopharmacology and immunotoxicology 44 (6) (2022)
Joerg Hoffmann, Rojin Etati, Cornelia Brendel, Andreas Neubauer, Elisabeth K M Mack
The Low Expression of Fc-Gamma Receptor III (CD16) and High Expression of Fc-Gamma Receptor I (CD64) on Neutrophil Granulocytes Mark Severe COVID-19 Pneumonia. Diagnostics (Basel, Switzerland) 12 (8) (2022)
Joerg Hoffmann, Michael C Thrun, Maximilian A Röhnert, Malte von Bonin, Uta Oelschlägel, Andreas Neubauer, Alfred Ultsch, Cornelia Brendel
Identification of critical hemodilution by artificial intelligence in bone marrow assessed for minimal residual disease analysis in acute myeloid leukemia: The Cinderella method. Cytometry. Part A : the journal of the International Society for Analytical Cytology (2022)
Joerg Hoffmann, Andreas Klameth, Martin Russwurm, Andreas Neubauer, Cornelia Brendel
Peripheral T-cell lymphoma immunophenotype in a patient with a history of Muromonab-CD3 therapy: A case report and a diagnostic dilemma. Cytometry. Part B, Clinical cytometry (2021)
Joerg Hoffmann, Marissa Rother, Ulrich Kaiser, Michael C Thrun, Christian Wilhelm, Andrea Gruen, Ute Niebergall, Ute Meissauer, Andreas Neubauer, Cornelia Brendel
Determination of CD43 and CD200 surface expression improves accuracy of B-cell lymphoma immunophenotyping. Cytometry. Part B, Clinical cytometry 98 (6) (2020)